Aspirin Study May Advance Cancer Treatment
Posted on: Thursday, 5 April 2007, 15:00 CDT
Australian scientists said a study of the effects of salicylates, including aspirin, on human cells might lead to new treatments and drugs to fight cancer.
Professor Bryan Williams, director of the Monash Institute of Medical Research, led a collaborative study that showed treating human cells with salicylates inhibits protein synthesis.
Inhibiting or slowing down protein synthesis reduces the accumulation of incorrectly folded proteins in cells, which reduces cellular stress and allows protein synthesis to return to normal, Williams said.
Our research into the mechanisms by which salicylates inhibit protein synthesis could lead to the design of more effective aspirin-like drugs for the treatment of diseases such as cancer, Williams added.
The study is detailed in the April issue of the Journal of Biological Chemistry.
Source: United Press International
Related Articles
- Gamida Cell Announces Feasibility Study With Weill Cornell Medical College
- Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
- Protein Synthesis Evolution is Challenged
- Protein Saves Cells, but May Cause Cancer
- Pancreas Cell Regeneration is Studied
- Stem Cells Develop into Human Brain Cells in Mice: Study
- Hopkins scientists uncover 'tags' that force proteins to cell surface
- Exercise Could Build Brain Cells in Elderly, Study Suggests
- Point Therapeutics Presents Positive Results in Phase 2 Talabostat Non-Small Cell Lung Cancer Study
- Point Therapeutics Achieves Interim Tumor Response Criteria in Phase 2 Non-Small Cell Lung Cancer Study; Company Advances Talabostat to Second Stage of Study
 |
 |
User Comments (0)
RSS Feeds